跳至主要内容
临床试验/EUCTR2009-012707-26-IT
EUCTR2009-012707-26-IT进行中(未招募)不适用

THERAPEUTIC EFFECTIIVENESS OF N-ACETYL-CYSTEINE AND ASCORBIC ACID IN PATIENTS WITH ALKAPTONURIA-OCHRONOSIS - Acetilcisteina-Ocronosi-SI/2009

AZIENDA OSPEDALIERA SENESE0 个研究点目标入组 50 人开始时间: 2009年5月25日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Inclusion Criteria:
  • - informed consent
  • - Established diagnosis of alkaptonuria
  • - Age:18-75
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Exclusion criteria
  • - NAC intolerance
  • - History of malignacy or neoplastic disease
  • - pregnant or lactanting females
  • - chronic or acute renal disease
  • - values of aspartate aminotrasferase (AST), alanine aminotrasferase (ALT) or bilirubin > 2 x upper limit of normal (ULN)
  • -history of excessive alcohol consuption or chronic alcohol induced disease
  • -patients who were treated with ascorbic acid or other antioxidant agents in the previous 30 days
  • - disorders that may interfere with the interpretation of the outcome data

研究者

发起方
AZIENDA OSPEDALIERA SENESE

相似试验